THE PHYSIOLOGY OF FOLLICLE MATURATION AND OVULATION
A S A FUNCTIONAL UNIT involved in the production of mature eggs and endocrine homeostasis, the ovarian follicle plays a central role in female reproductive physiology. It is composed of an external layer of theca cells in continuity with the ovarian stroma. Separated from the theca layer by a basal lamina, mural granulosa cells are the major epithelial component of the follicle. During follicular growth, oocytes assume a central position in this structure and are surrounded by, and in close contact with, replicating granulosa cells (1, 2) . With the development of the antral cavity, the somatic granulosa cells surrounding the oocyte, termed cumulus cells, detach from the mural layer and become phenotypically distinct. Once transformed into highly specialized cells embedded in a mucous matrix just before ovulation, they will follow the oocyte into the reproductive tract (2) . The complex multilayered structure of the follicle and the major remodeling that occurs during maturation suggest that integrating signals are required for the concerted function of cells as diverse as theca cells and oocytes (1) .
Growth and differentiation of the follicle is orchestrated by gonadotropins. Exposure to FSH is indispensable for the growth of the immature follicles and for steroidogenic output (3) . Conversely, the LH surge produces profound changes in all follicular cells that are required for the ovulation of a mature egg and development of a corpus luteum (2, 4) . These changes include reprogramming of mural granulosa cells to become luteal cells, oocyte reentry into the cell cycle, and cumulus cell secretion of components of an extracellular matrix that is an essential vestment of the oocyte during its transit in the reproductive tract and fertilization (4, 5) .
LH acts via interaction with the cognate LH receptor (LHR), a member of the large superfamily of G proteincoupled receptors (GPCRs) (6, 7) . This receptor is coupled primarily to G s protein and activation of adenylyl cyclase (8) . Thus, the primary signal emanating from this receptor is cAMP accumulation in theca and granulosa cells; indeed, this second messenger is thought to mediate most of the changes that occur before ovulation. However, additional signaling path-ways are clearly activated during FSH and LH action. These may require receptor interaction with G proteins other than G s , or branching of the cAMP cascade on to other signaling modules (7) . Thus, although LH clearly signals through cAMP-dependent protein kinase (protein kinase A) activation, other kinases likely are involved in mediating the complex sets of changes affecting granulosa cell function before ovulation. The MAPK module, protein kinase B (AKT) and serum and glucocorticoid inducible kinase, are kinases known to be involved in gonadotropin signaling (7) . Here, we will review evidence indicating that LH signaling utilizes yet another kinase family, the receptor tyrosine kinases involved in the epidermal growth factor (EGF) network.
The pattern of LHR expression in the ovarian follicle has been investigated by hormone binding and mRNA expression studies. LHRs are expressed almost exclusively on theca during early stages of follicle development and appear in mural granulosa cells later on (9) (10) (11) . LHRs in cumulus cells and oocytes have been difficult to detect, are virtually absent in the mouse cumulus, and are expressed at one tenth the concentration of mural cells in the rat cumulus (11) . This restricted pattern of receptor expression is puzzling in view of the well-established effects of LH on both cumulus cells and oocytes. To reconcile these differences, it has been proposed that either paracrine signals or intercellular communications are required for propagation of LH effects in the follicle from the periphery toward the cumulus-oocyte complex (COC). The junctional complexes among the mural granulosa layer, cumulus cells, and oocytes play an important role in propagating the LH signal and integrating the functions of these cells (12, 13) . Indeed, genetic ablation experiments indicate that gap junctions are essential for growth of the follicle and production of healthy oocytes competent to develop into an embryo (14) . That follicular development and ovulation require continuous oocyte-somatic cell cross talk is a firmly established concept; oocytes have profound effects on the surrounding somatic cells via secretion of peptide hormones and growth factors (15) . Two closely related members of the TGF␤ family, growth-determining factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15), are secreted by the oocyte and are critical for the integration of cumulus cell differentiation with oocyte maturation (15) . These factors, as well as other less-defined molecules, are necessary for maintaining the phenotypic properties of cumulus granulosa cells, among which is the suppression of LHR expression (16) .
Conversely, paracrine regulation from mural granulosa cells to the cumulus cells and the oocyte at the time of ovulation has been difficult to assess. It has been hypothesized that mural granulosa cells must generate signals that maintain meiotic arrest as well as oocyte reentry into the cell cycle (17) . In addition to diffusion of signals through gap junctions (12) , local prostaglandin production undoubtedly has a critical role in cumulus expansion and restructuring of the follicle before ovulation, as documented by the effects of cyclooxygenase-2 (COX2) and prostaglandin receptor knockouts in mice (18, 19) . However, the roles of prostaglandins in oocyte maturation are less clear. The arrangement of signaling networks between different cell layers in the follicle may have additional ramifications, as studies in bovine follicles have indicated that theca cells may exert control of oocyte meiotic arrest and/or maturation (20). More recently, insulin-like factor 3 has been proposed to be one such signal produced by theca cells that affects oocyte maturation (21).
Here we will review evidence in support of a critical role for the EGF network in integrating the function of granulosa/cumulus cells/oocytes within the preovulatory follicle.
EGF NETWORK AND ITS INVOLVEMENT IN GPCR SIGNALING
EGF is one of the first factors to be identified in mammals for its growth-promoting activity and to have its properties extensively characterized. Its critical function during development, particularly in the gonads, extends well beyond mammalian species. In Drosophila, multiple growth factors related to the EGF family [Spitz (22), Gurken (23), Keren (24), Vein (25), and Argos (26)] interact with a single EGF-like receptor [Drosophila EGF receptor (DER)] (27, 28). These growth factors are often synthesized as inactive precursors and are processed by a protease termed "Rhomboid" (29), which is unrelated to the ADAM (a disintegrin and metalloprotease) family of ectoproteases (see below). A large body of work points to an important role for EGF signaling in the ovary, because Gurken is expressed during oocyte development and constitutes an important signal for pattern formation and follicular cell fate determination (30). Moreover, Spitz is involved in stem cell renewal during Drosophila spermatogenesis (31).
As early as the 1970s when EGF function was first explored, it was suggested that this growth factor plays a role in follicle function. Gospodarowicz and Bialecki (32) showed that EGF could stimulate the replication of granulosa cells, thereby suggesting its involvement in follicle growth. In the following years, a number of studies have implicated EGF in growth and differentiation of the ovarian follicle and steroidogenesis (33, 34).
It is now established that EGF is only one member of a large family of closely related proteins that includes TGF␣, heparin-binding EGF-like growth factor (HB-EGF), amphiregulin (AREG), epiregulin (EREG), betacellulin (BTC), epigen, and neuregulins (35). Many of these EGF-related growth factors have only recently been identified for their mitogenic activities, purified, and their properties characterized. AREG was initially isolated from serum-free conditioned medium of MCF-7 human breast carcinoma cells and is a potent mitogen for fibroblasts and keratinocytes, but not A431 human epidermoid carcinoma cells (36, 37). EREG was purified from conditioned medium of the mouse fibroblast-derived tumor cell line, NIH-3T3 T7 (38). It is a potent mitogen for hepatocytes; however, it inhibits the growth of several epithelial cell lines. BTC was initially detected as a mitogen from pancreatic ␤-cell tumors and for BALB/c 3T3 cells (39). Thus, these growth factors have variable effects on epithelial and nonepithelial cells and can act as mitogens as well as inhibitors of replication depending on the cell type.
The genes coding for AREG, EREG, and BTC growth factors are clustered in a region of mouse chromosome 5, rat chromosome 14, and human chromosome 4 (40, 41)(see also Entrez Gene Http://www.ncbi.nih.gov/entrez/); however, no data are available as to whether the expression of these genes is somehow coordinated. These growth factors share a motif of six similarly spaced conserved cysteine residues and an EGF-like domain. Although identified as soluble biologically active molecules, they are all synthesized as integral membrane precursors with a single membrane-spanning domain (35). They are released or shed as soluble mature peptides by proteolytic cleavage of the ectodomain at the membrane surface. Early findings suggested that the membrane-bound precursors are biologically active (42) (43) (44) , even though a majority of studies suggest that processing is a critical step in the activation (45, 46) . Members of the ADAM family of proteases have been implicated in the proteolytic release of cell-surface proteins including growth factors, cytokines, and cell adhesion molecules (45, 47, 48) . However, dissecting the ADAMs involved in EGF-like growth factor shedding has not provided a unifying picture. TACE (TNF␣-converting enzyme)/ADAM17 is involved in AREG shedding in head and neck cancer cells (49) . Conversely, ADAM9, -10, and -12 have been implicated in HB-EGF processing (50) (51) (52) (53) (54) . In addition, EGF shedding has been shown to be TACE independent in some cells (55) , indicating that other ADAMs may regulate the processing of EGFR ligands in a cell-specific manner.
An additional important feature of EGF-like growth factor shedding is that it is regulated by GPCR signaling. For example, treatment of squamous cell carcinoma cells with GPCR agonists such as lysophosphatidic acid and carbachol stimulates proteolytic cleavage and release of AREG (56) . The phorbol ester phorbol myristate acetate also rapidly stimulates the shedding of HB-EGF via activation of the Raf/MAPK cascade (57) . Thus, it has been proposed that GPCRmediated activation of EGF-like growth factor shedding is a mechanism of the branching of the GPCR signal (58) on to a growth factor-signaling pathway.
All the EGF-like growth factors bind with different specificity and activate four related receptors. The EGF receptor (EGFR) subfamily belongs to the large superfamily of receptor tyrosine kinases and includes EGFR (ErbB1), a receptor with unknown ligand (ErbB2/ neu, HER2), ErbB3 (HER3), and ErbB4 (HER4) (35, 59). ErbB3 lacks kinase activity and signals by dimerization with another ErbB receptor. There is growing evidence that different combinations of ligands and receptor homo-and heterodimers allow for a wide variety of signals and different distal responses.
LH STIMULATES EGF-LIKE GROWTH FACTOR mRNA EXPRESSION
In the 1980s, numerous studies implicated EGF in the growth of ovarian follicles and modulation of the function of granulosa cells (reviewed in Ref. 34). In general, EGF was considered a growth-promoting factor for the follicle with negative effects on FSH-regulated steroidogenesis and differentiation of granulosa cells in preantral follicles (34). This body of work contributed to the overall scenario of FSH as the major orchestrator of follicle growth and of its effects being finely modulated by growth factors such as EGF and IGF-I (60).
More recent studies have provided additional insight into the complexity of the EGF network in the ovary later during the periovulatory period. Subtraction analysis of genes induced by human chorionic gonadotropin (hCG) in rat follicles has shown that EREG mRNA is induced by hCG (61) . These authors noted that the temporal pattern of expression of this mRNA is superimposable to that of COX2 with maximum mRNA levels at 3 h, excluding a causative link in the expression of these genes. We have found that in vivo hCG injection or exposure of mouse follicles to LH in vitro produces a rapid increase in mRNAs coding for EREG, AREG, and BTC, three members of the EGF-like growth factor family (62) . Conversely, HB-EGF mRNA levels decrease after LH/hCG, suggesting a switch in the pattern of growth factor expression after the LH surge (62, 63) . Detailed time course studies using microarray analysis indicate that the maximum levels of EREG and AREG mRNAs are attained 2 h after hCG administration in vivo with the mRNAs rapidly declining afterward, therefore preceding COX-2 mRNA maximal expression by 1 h (Fig. 1) . The accumulation of BTC mRNA is somewhat delayed as it reached a maximum after 5 h (Fig. 1) . Similar data were obtained using Northern blotting in mouse or RT-PCR analysis in rat ovaries (62, 64) .
Underscoring the physiological significance of the LH/hCG regulation, EGF-like growth factor expression also has been observed in vivo after the endogenous gonadotropin surge on the evening of proestrus in the rat (65) and in the mouse (Hsieh, M., unpublished data). Thus, both exogenous and endogenous LH produces a dramatic increase in the expression of these three growth factors. In contrast to these direct findings, previous attempts to monitor EREG gene transcription with a ␤-galactosidase reporter inserted by homologous recombination have been unsuccessful, most likely due to the transient nature of EREG induction and the inappropriate timing for the sampling of the ovary (40). This hCG/LH-regulated expression of EGF-like growth factors does not appear to be limited to rodents because similar findings have been published recently with human granulosa cell cultures (66) and in cows (67) .
In the mouse, the expression of EGF-like growth factor mRNAs in the first 3 h after hCG stimulation was most evident in the mural granulosa cell compartment as detected by in situ hybridization (62) . More sensitive RT-PCR studies have detected AREG expression in cumulus cells of the rat (Tsafriri, A., personal communication), but it is not clear whether this is a species difference or is due to the different technique used. Clearly, further studies are required to define the exact spatial and temporal pattern of expression of these growth factors in the mural and cumulus cell compartments.
EVIDENCE FOR BIOACTIVE EGF-LIKE GROWTH FACTOR ACCUMULATION IN THE PREOVULATORY FOLLICLE
Several lines of evidence indicate that the increased EGF-like growth factor mRNAs are translated into the corresponding proteins. Metabolic labeling of follicles and immunoprecipitation of the labeled peptide showed that LH promotes the accumulation of a polypeptide of 32 kDa that corresponds to the EREG precursor and processing intermediates (62) . In addition, antibodies against EREG were used to label the surface of granulosa cells at different times after hCG injection. Flow cytometry further confirmed that the EREG precursor becomes detectable 2 h after LH stimulation and increases thereafter (62) (Fig. 1) . In agreement with the mRNA data, the EREG signal is greatly decreased in mice deficient in phosphodiesterase 4D that exhibit defective ovulation but normal luteinization in response to LH/hCG stimulation. These data, together with the evidence of EGFR transactivation (see below), strongly support the view that LH promotes the expression of bioactive EGF-like growth factors.
Indeed, data already present in the literature indicated that immunoreactive EGF is detectable in the follicular fluid of human ovaries, and in some cases this accumulation has been correlated to oocyte quality and fertilization competence (68) (69) (70) . In addition, EGF-like activity has been observed in pig follicular fluid (71) . It is unclear if this activity is truly due to EGF or to cross-reactivity to the newly identified EGF-like growth factors. In the mouse ovary, EGF mRNA levels were not affected by LH/hCG, suggesting that EGF expression is not up-regulated before ovulation in this species (Fig. 1) . A possibility that should be considered is that EGF-like activity is generated by shedding of EREG, AREG, or BTC in the fluid. Further experiments are clearly needed to address this issue. Finally, granulosa cells express a number of ADAMs including ADAM17/TACE, which potentially may be involved in processing of the EGF-like growth factor precursors (72) . Thus, these ectoproteases may be involved not only in matrix remodeling, but also may have important signaling functions.
EGF-LIKE GROWTH FACTORS MIMIC THE LH EFFECTS
It has long been known that purified EGF induces germinal vesicle breakdown (GVBD) and nuclear maturation when added to COCs or to intact follicles in culture (73) (74) (75) . Moreover, EGF improves cytoplasmic maturation of oocyte cultured in vitro (76, 77) . EGF is also known to produce cumulus expansion as efficiently as FSH in COC cultures (78) . Finally, Das et al. (79) made the interesting observation that human follicular fluid promotes mouse oocyte maturation in vitro and that this activity could be in part neutralized by removal of EGF from the fluid. In view of these findings, and the fact that common receptors are shared by EGF and related growth factors, we investigated the effect of EREG, AREG, and BTC on oocyte maturation and cumulus expansion. All three growth factors induced oocyte maturation in follicle cultures as efficiently as LH (62) . More importantly, the time course of oocyte maturation induced by LH is slower than that observed with EREG and AREG. This finding opens the possibility that these growth factors act downstream of LH. In a manner similar to that observed with EGF (74), EREG and AREG require cumulus cells to exert their effects, as denuded oocytes maintained in meiotic arrest by phosphodiesterase inhibitors did not undergo oocyte maturation (62) . Thus, in spite of the fact that EGFR expression has been reported for oo- (80) and that some direct effects of EGF on oocytes have been observed (76, 81) , we favor the hypothesis that most of the EGF-like growth factor effects on oocyte nuclear and cytoplasmic maturation are indirect and dependent on cumulus cells. According to this view, EREG and AREG stimulation of cumulus cells must trigger changes that signal meiotic resumption to the oocytes. One possibility is that closure of the gap junctions between oocytes and granulosa cells may be a determining event (82) . However, this interruption of physical coupling before chromatin condensation and GVBD in the oocytes is a controversial issue, because several reports have demonstrated that communications between the two compartments persists well into oocyte maturation (83, 84) . An obligatory role of gap junctions is also inconsistent with the discovery that oocytes are autonomous in terms of cAMP production sufficient to maintain the meiotic arrest (85, 86) , and that a GPCR coupled to adenylyl cyclase expressed in mouse oocytes plays a critical function in maintenance of meiotic arrest (87) .
In the same vein, EREG, AREG, and BTC produce robust cumulus expansion both in follicle cultures and isolated COCs. Similarly, the three growth factors stimulate the expression of COX2, TSG6, and HAS2 mRNAs (62) , genes critical for matrix remodeling in the COC (72) .
A crucial issue not completely resolved is whether the accumulation of these growth factors occurs in the follicle with a time course compatible with an intermediate role for GVBD, nuclear and cytoplasmic maturation, and cumulus expansion. Oocyte nuclear envelope breakdown occurs 3-4 h after exposure to LH/ hCG in vivo and in vitro. Detailed time courses using microarray analysis show that the mRNAs coding for EREG and AREG reach a maximum at 2 h (Fig. 1) , and at this time immunoreactive EREG becomes detectable in granulosa cells (62) . Because EGF-like growth factors induce oocyte maturation in less than 2 h, the appearance of these growth factors on granulosa cells is compatible with a mediatory role in LH action (Fig.  2) . It should also be emphasized that EREG and AREG accumulate at the same time and should have additive or synergistic effects on maturation. We have recently observed that oocyte maturation occurs with a delay in AREG null mice (Hsieh, M., unpublished observation), a finding consistent with the idea that AREG and EREG synergize to accelerate maturation. A more detailed time course of the accumulation of AREG and EREG proteins should address this issue.
Another possibility not yet explored is that a pool of growth factor precursors is already present on the granulosa cell surface and LH promotes their shedding, as shown for other GPCRs. This would imply that early LH-regulated events may be mediated by shed growth factors, in addition to the dependence of delayed (2-3 h) events on de novo synthesis of EGF-like growth factors. Although EREG could not be detected on the surface of the granulosa cells before hCG stimulation (62), nor could an increase in EGFR phosphorylation be detected 1 h after LH stimulation (see below), the activation of the EGF network needs to be investigated in the first hour of LH stimulation.
LH EFFECTS IN THE FOLLICLE REQUIRE EGFR SIGNALING
From the above data, a model can be proposed whereby LH stimulation of mural granulosa cells triggers the accumulation of the three EGF-like growth factors and these, in turn, communicate the LH stimulus, by themselves or in conjunction with other signals (i.e. cAMP), to the COC (Fig. 2) . Two additional conditions should be verified to consolidate this model. First, LH stimulation should cause a delayed increase in EGFR phosphorylation. Second, any pharmacological agent interfering with the EGF signaling network should block the LH effects. Both conditions have been fulfilled with the following experiments done in mouse and rat. Analysis of the phosphorylation state of the EGFR in mouse ovaries shows that hCG injection causes an increase in phosphorylation that becomes visible in about 2 h with a maximum reached at 3-4 h (62). Similar results have been obtained with rat follicles (64) . These findings are in agreement with the view that the LH signal eventually branches to EGFRtyrosine kinase signaling. To determine whether EGFR phosphorylation is required for LH action, inhibitors selective for the EGFR tyrosine kinase were used. The selective EGFR kinase inhibitors, AG1478 or C56, blocked oocyte maturation in mouse follicles with EC 50 in the order of 100-300 nM. These concentrations are somewhat higher than those observed in cultured cells; however, the concentrations of AG1478 that are necessary to block the LH effect are identical to the concentrations required to block the effect of EREG or AREG (62) . Consistent with the specific effect of these compounds, the related but inactive compound, AG43, was without effect. In a more elaborate paradigm where the inhibitor was injected into the ovarian bursa of the rat, a 50% decrease in ovulation was produced, and numerous mature follicles with entrapped oocytes were observed in the injected side as compared with the contralateral vehicle-injected bursa (64) . Thus, pharmacological inhibition of this kinase blocks the LH effects in both in vitro and in vivo models. More importantly, the in vivo data imply that EGFR phosphorylation is somehow required also for follicle rupture and ovulation. A role of EGFR in reproductive processes has been difficult to assess by genetic strategies because null mutations in this receptor produce embryo or neonatal mortality. However, disruption of fertility has been observed when EGFR signaling is impaired in mice homozygous for the hypomorphic Egfr allele, waved-2 (88). The defect has been placed in hypothalamic function (89) , but direct effects on the ovary had not been considered. EGFR activation produces signaling through numerous downstream pathways, the most prominent one being the MAPK cascade. Indeed, treatment of COCs or follicles with EGF produces a very robust increase in ERK phosphorylation. Similarly, LH/hCG produces a robust increase in ERK phosphorylation that is required for oocyte maturation (90) and for gap junction phosphorylation (82) . It is therefore tempting to speculate that some of the LH effects on MAPK activation are mediated by shedding of these EGF-like growth factors.
An additional pharmacological manipulation consistent with a role of EGF-like growth factor shedding in LH action is the observation that the matrix metalloprotease (MMP) inhibitor GM6001 completely blocks LH-stimulated oocyte maturation in rats (64) and partially in mice (Hsieh, M., unpublished observation). The specificity of the inhibitor is suggested by the finding that in both cases EREG-induced maturation was not affected by the MMP inhibitor. These findings further indicate that LH action requires MMP activity, and when this activity is blocked, it can be bypassed by addition of the free ligand, EREG.
SUMMARY AND CONCLUSIONS
The data summarized above strongly suggest that LH stimulation of the ovarian follicle involves activation of the EGF network. In all the experiments thus far performed, LH effects and EGFR signaling could not be dissociated by pharmacological and genetic approaches. A model depicting this property of LH signaling is reported in Fig. 2 . According to this model, LH activation of mural granulosa cells stimulates cAMP signaling, which, in turn, induces the expression of EREG, AREG, and BTC. These growth factors function in either an autocrine/juxtacrine fashion within the mural layer, or they diffuse to activate cumulus cells. Activation of EGFR signaling in cumulus cells, together with cAMP priming, triggers oocyte maturation and cumulus expansion. Obviously, additional data are required to consolidate this model. However, the presence of redundant systems represents a formidable challenge to the use of a genetic approach to dissect the function of the EGF network in the follicle. Although individual knockouts of the AREG, EREG, and BTC are available (91, 92) , no gross disruptions of fertility were observed in any of these mice. In general, disruption of any one of them produced very mild phenotypes, consistent with the redundancy of the system. Conversely, disruption of the EGFR produces profound neonatal phenotypes but prevents analysis of fertility. Thus, more elaborate strategies are necessary to obtain genetic evidence of the exact role of this network in ovarian follicles.
These data supporting a branching of LH/hCG signaling to the EGF network in the follicle should prompt the reconsideration of many of the findings on the long-term effects of gonadotropins. In many instances, effects of signaling pathways other than cAMP signaling should be reinvestigated to determine the branching on to EGFR activation. Similarly, some of the mitogenic effects of gonadotropins during early follicle growth or in testes may be dependent on activation of this pathway. Indeed, an increase in EREG after FSH stimulation of immature preantral follicles has been observed (93) . A better understanding of the possible involvement of EGF-like growth factors in follicle growth should prompt a reassessment of growth media formulation for IVM, in view of the wellestablished beneficial effects of EGF on oocyte acquisition of developmental competence and overall egg quality (76, 77 
